Ginkgo Bioworks Holdings, Inc. (DNA) concluded the recent trading session at $12.74, signifying a -4.85% move from its prior day's close.

Ginkgo Bioworks Holdings has maintained its fair value price target at $12.00 per share, with only slight shifts in the underlying assessment from market analysts. The minor increase in the discount ...

Ginkgo Bioworks Holdings, Inc. today announced its results for the third quarter ended September 30, 2025. The update, including a webcast slide presentation with additional details on the third ...

Ginkgo Bioworks Holdings, Inc. (DNA) closed at $12.78 in the latest trading session, marking a -2.67% move from the prior day. This change lagged the S&P 500's daily loss of 0.53%. Elsewhere, the Dow ...

Ginkgo reaffirmed its full-year 2025 revenue guidance of $167 million to $187 million, with Cell Engineering revenue expected to be $117 million to $137 million and Biosecurity revenue expected to be ...

The consensus estimate for Q3 2025 revenue is $38.85 million, and the earnings are expected to come in at -$1.24 per share.

Ginkgo Bioworks Holdings (DNA) is scheduled to announce Q3 earnings results on Thursday, November 6th, after market close. The consensus EPS Estimate is -$1.24 and the consensus revenue estimate is ...

Ginkgo Bioworks (NYSE: DNA) today announced that the company has extended its multi-year strategic partnership with Bayer to ...

Ginkgo Bioworks announced today that it has been awarded a contract through the Biomedical Advanced Research and Development Authority's (BARDA) Biopharmaceutical Manufacturing Preparedness Consortium ...

To truly deliver on their promise, nitrogen-fixing microbes need to up their game, says Ginkgo ag bio head, Michael Miile.

LOS ANGELES, CALIFORNIA / ACCESS Newswire / October 16, 2025 / Lunai Bioworks, Inc. (Nasdaq:LNAI), today announced that it has regained compliance with Nasdaq's minimum bid price requirement. On April ...

GoldMining Inc. stock has more than doubled in 2025, vastly outperforming the S&P 500 and gold ETFs thanks to its high leverage to the price of gold. GLDG is a speculative, high-risk, high-reward ...